Hodgkin lymphoma: open trials in Denmark

• 2023-504264-41-00

  A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of Glofitamab in Monotherapy and in Combination with Chemoimmunotherapy in Pediatric and Young Adult Participants with Relapsed/Refractory Mature B-Cell Non-Hodgkin Lymphoma

  Trial Treatment · Phase 1/2 · F. Hoffmann-La Roche AG

  Rigshospitalet, Copenhagen Oe

  Registry updated 2026-11-04

• NCT06788509

  A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring

  Trial Treatment · Phase 1 · Janssen Research & Development, LLC

  Rigshospitalet, Copenhagen Oe · Odense University Hospital, Odense C

  Registry updated 2026-11-04

• NCT06526793

  Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL

  Trial Treatment · Phase 2 · AstraZeneca

  Rigshospitalet, Copenhagen Oe · Lillebaelt Hospital, Vejle

  Registry updated 2026-10-14

• NCT07817641

  Proton Therapy for Mediastinal Lymphoma (PROMLY)

  Trial Treatment · Copenhagen University Hospital, Rigshospitalet

  Dept. of oncology, Copenhagen

  Registry updated 2026-09-14

• NCT04685616

  Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

  Trial Treatment · Phase 3 · University College, London

  Aarhus University Hospital, Aarhus N · Rigshospitalet, Copenhagen Oe

  Registry updated 2026-07-08

• NCT05840575

  Investigating Cognitive Impairment in Young Patients With Cancer Prospectively

  Research · Copenhagen University Hospital, Rigshospitalet

  Rigshospitalet, Copenhagen

  Registry updated 2023-05-03

All Hodgkin lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error